Latest Dividend Payments News

Cue Energy Resources reported a 10.4% increase in revenue to $54.8 million for FY2025, driven by stable production and higher gas prices, but net profit after tax halved to $6.32 million due to rising costs. The company declared a final dividend of 0.5 cents per share.

Monash IVF Group reported steady FY25 financial results with revenue and EBITDA growth, while managing clinical incidents and a CEO transition. The company outlines cautious FY26 guidance amid industry headwinds.

Monash IVF Group reported a 6.7% revenue increase to $271.9 million in FY25 but saw an 8.1% decline in underlying net profit after tax to $27.4 million, impacted by market softness and operational incidents. The company outlines cautious FY26 guidance amid ongoing sector headwinds.

Diversified United Investment Limited has announced a fully franked ordinary dividend of AUD 0.09 per share for the six months ending June 2025, accompanied by a Dividend Reinvestment Plan with no discount.

Helia Group Limited has announced a combined ordinary and special dividend totaling AUD 0.43 per share, set for payment in mid-September 2025.

DUG Technology’s latest financials reveal a modest revenue decline and a widening net loss for the fiscal year ended June 2025, with no dividends declared.

Inghams Group Limited has announced a fully franked ordinary dividend of AUD 0.08 per share for the six months ending June 28, 2025, signaling steady shareholder returns.

Suncorp Group Limited has updated its dividend details for the half-year ending June 2025, confirming a fully franked ordinary dividend of AUD 0.49 per share payable in September, with clarified currency payment arrangements.

FFI Holdings Limited has announced a fully franked ordinary dividend of AUD 0.125 per share for the fiscal year ending June 2025, alongside a Dividend Reinvestment Plan offering a 5% discount.

Cadence Opportunities Fund Limited reported a 36% drop in profit after tax for FY2025 but maintained its fully franked final dividend at 7.0 cents per share, signaling confidence despite softer earnings.

Globe International Limited reported a decline in revenue and profit for FY25, reflecting a strategic shift away from non-core brands. Despite this, the company maintains strong profitability in Australia and a solid cash position, while declaring a fully franked dividend of 20 cents per share.

Healius reported a 5.7% rise in FY25 revenue with underlying EBIT meeting consensus, buoyed by strong pathology growth and a significant profit from the Lumus Imaging sale. Despite challenges at Agilex Biolabs and a major goodwill impairment, the company targets improved margins by 2027.